The stock of Alignment Healthcare Inc (NASDAQ: ALHC) has increased by 13.64 when compared to last closing price of 11.88. Despite this, the company has experienced a 15.38% gain in its stock price over the last five trading sessions. globenewswire.com reported 2025-01-13 that ORANGE, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE) — Alignment Healthcare, Inc. (NASDAQ: ALHC), an award-winning Medicare Advantage (MA) company, today announced Jan. 1 health plan membership of approximately 209,900, representing a 35% year-over-year increase in health plan membership when compared to membership as of Jan. 1, 2024. Additionally, the company expects to have 225,000 to 231,000 health plan members as of Dec. 31, 2025, representing growth of approximately 22% to 25% relative to the midpoint of its year-end 2024 membership guidance provided on Oct. 29, 2024.
Is It Worth Investing in Alignment Healthcare Inc (NASDAQ: ALHC) Right Now?
Additionally, the 36-month beta value for ALHC is 1.43. There are mixed opinions on the stock, with 8 analysts rating it as a “buy,” 1 rating it as “overweight,” 3 rating it as “hold,” and 0 rating it as “sell.”
The public float for ALHC is 92.15M and currently, short sellers hold a 10.39% ratio of that float. The average trading volume of ALHC on January 14, 2025 was 1.72M shares.
ALHC’s Market Performance
ALHC stock saw an increase of 15.38% in the past week, with a monthly gain of 16.28% and a quarterly increase of 19.36%. The volatility ratio for the week is 6.71%, and the volatility levels for the last 30 days are 5.43% for Alignment Healthcare Inc (ALHC). The simple moving average for the past 20 days is 19.79% for ALHC’s stock, with a 45.31% simple moving average for the past 200 days.
Analysts’ Opinion of ALHC
Many brokerage firms have already submitted their reports for ALHC stocks, with Stephens repeating the rating for ALHC by listing it as a “Overweight.” The predicted price for ALHC in the upcoming period, according to Stephens is $17 based on the research report published on December 03, 2024 of the previous year 2024.
BofA Securities gave a rating of “Buy” to ALHC, setting the target price at $11 in the report published on May 30th of the previous year.
ALHC Trading at 12.67% from the 50-Day Moving Average
After a stumble in the market that brought ALHC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -5.26% of loss for the given period.
Volatility was left at 5.43%, however, over the last 30 days, the volatility rate increased by 6.71%, as shares surge +15.09% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +15.29% upper at present.
During the last 5 trading sessions, ALHC rose by +15.38%, which changed the moving average for the period of 200-days by +187.23% in comparison to the 20-day moving average, which settled at $11.27. In addition, Alignment Healthcare Inc saw 20.00% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ALHC starting from KAO JOHN E, who sale 90,000 shares at the price of $13.06 back on Jan 13 ’25. After this action, KAO JOHN E now owns 2,273,100 shares of Alignment Healthcare Inc, valued at $1,175,494 using the latest closing price.
JEK TRUST U/A DTD 02/08/2021, the Director of Alignment Healthcare Inc, proposed sale 270,000 shares at $11.88 during a trade that took place back on Jan 13 ’25, which means that JEK TRUST U/A DTD 02/08/2021 is holding shares at $3,207,600 based on the most recent closing price.
Stock Fundamentals for ALHC
Current profitability levels for the company are sitting at:
- -0.05 for the present operating margin
- 0.1 for the gross margin
The net margin for Alignment Healthcare Inc stands at -0.06. The total capital return value is set at -0.36. Equity return is now at value -95.13, with -19.71 for asset returns.
Based on Alignment Healthcare Inc (ALHC), the company’s capital structure generated 0.65 points at debt to capital in total, while cash flow to debt ratio is standing at -0.68. The debt to equity ratio resting at 1.85. The interest coverage ratio of the stock is -5.14.
Currently, EBITDA for the company is -105.3 million with net debt to EBITDA at 1.27. When we switch over and look at the enterprise to sales, we see a ratio of 1.0. The receivables turnover for the company is 17.77for trailing twelve months and the total asset turnover is 3.56. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.60.
Conclusion
In conclusion, Alignment Healthcare Inc (ALHC) has seen better performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
